COMMUNIQUÉS West-GlobeNewswire

Antares Pharma to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
30/08/2018
EWING, N.J., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Rodman & Renshaw 20 th Annual [...]
Merus to Participate in Citi’s 13th Annual Biotech Conference
30/08/2018
UTRECHT, The Netherlands, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that [...]
CRISPR Therapeutics to Present at Upcoming Investor Conferences
30/08/2018
ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 30, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]
Tonix Pharmaceuticals to Present at Upcoming September Investor Conferences
30/08/2018
NEW YORK, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present a company [...]
VBL Therapeutics Announces Publication of Positive New Data on its Lecinoxoid Drug Candidates for the Treatment of Renal Fibrosis
30/08/2018
These data, together with positive preclinical NASH data previously presented, support the potential of VBL’s lecinoxoid pipeline Recently granted US patent provides patent protection for lecinoxoids treatment of [...]
ChromaDex Announces Participation at The 20th Annual Global Investment Conference in New York City September 5, 2018
30/08/2018
IRVINE, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN® and [...]
Infant Bacterial Therapeutics has been approved for listing on the main market of Nasdaq Stockholm
30/08/2018
Nasdaq Stockholm’s Listing Committee has approved the admission of Infant Bacterial Therapeutics AB’s (“IBT” or the “Company”) shares of series B for trading on the main market of Nasdaq Stockholm. The approval is [...]
Swedish hospitals successfully complete Acarix CADScor®System evaluations vs. current best clinical practice for ruling out Coronary Artery Disease.
30/08/2018
Press release Malmö, August 30, 2018 Swedish hospitals successfully complete Acarix CADScor®System evaluations vs. current best clinical practice for ruling out Coronary Artery Disease. Acarix AB (publ) ("Acarix"), [...]
LIDDS Delårsrapport april-juni 2018
30/08/2018
ANDRA KVARTALET (APRIL - JUNI 2018) Nettoomsättningen uppgick till 0,0 (0,4) MSEK Kostnaderna uppgick till 2,2 (1,6) MSEK Resultatet före och efter skatt uppgick till -2,2 (-1,2) MSEK Resultat per aktie uppgick till -0, [...]
Notification from Oasmia Pharmaceutical AB
30/08/2018
Oasmia Pharmaceutical AB hereby issues a notification that the Company’s loan from Nexttobe AB has according to earlier communication been overtaken by a consortium. Due date for the loan is September 30 th 2019. Notes [...]
Herantis Pharma Oyj: Manager's Transactions - Pekka Simula
30/08/2018
Herantis Pharma Oyj: Manager's Transactions - Pekka Simula Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager's Transactions - James Phillips
30/08/2018
Herantis Pharma Oyj: Manager's Transactions - James Phillips Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager's Transactions - Aki Prihti
30/08/2018
Herantis Pharma Oyj: Manager's Transactions - Aki Prihti Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager's Transactions - Frans Wuite
30/08/2018
Herantis Pharma Oyj: Manager's Transactions - Frans Wuite Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager's Transactions - Pekka Mattila
30/08/2018
Herantis Pharma Oyj: Manager's Transactions - Pekka Mattila Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager's Transactions - Timo Veromaa
30/08/2018
Herantis Pharma Oyj: Manager's Transactions - Timo Veromaa Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager's Transactions - Antti Vuolanto
30/08/2018
Herantis Pharma Oyj: Manager's Transactions - Antti Vuolanto Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Patrick Bourdet, fondateur et ancien PDG d’AREVA Med (Orano Med) entre au capital du Radiopharma Logistics Group (RLG)
30/08/2018
Médicine Nucléaire/ Radiopharmacie/Logistique Loos, France, siège d'Isovital, 28 aout 2018 : Patrick Bourdet, fondateur et ancien PDG d’AREVA Med (Orano Med) entre au capital du Radiopharma Logistics Group (RLG). [...]
Shire plc: Rule 2.9 Announcement
30/08/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 30 August 2018 [...]

Pages